Pfizer, Moderna COVID-19 vaccines likely in India soon
The Centre is likely to grant indemnity to foreign drugmakers like Pfizer and Moderna, along the lines of the approach adopted by the US and other countries that have rolled out their COVID-19 vaccines
Pfizer, Moderna vax reduce infection risk by 91%
The Centre is likely to grant indemnity to foreign drugmakers like Pfizer and Moderna, along the lines of the approach adopted by the US and other countries that have rolled out their COVID-19 vaccines.
Like other nations, the Indian government is also expected to grant indemnity to these companies if they seek drug regulator's nod for the Emergency Use Authorisation (EUA).
"It is expected to grant indemnity against legal proceedings along the lines of what has been granted in other countries for Pfizer and Moderna vaccine companies,"
Meanwhile, in another development that would bolster the availability of vaccines, the Drug Controller General of India (DCGI) has waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such firms.
The decision, taken by India's apex drug regulator, comes in the backdrop of Pfizer and Cipla putting forth similar demands during negotiations to supply imported vaccines to India.
